Gilead Sciences : GILD

All Gilead Sciences Articles

732 Articles

Jon C. Ogg | Nov 23, 2011 at 8:02 AM EST

Top Analyst Upgrades & Downgrades (AET, BIG, CIT, FMCN, GILD, JASO, LDK, MDR, MU, SNH, VE, INT)

These are some of Wednesday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls. Aetna, Inc. (NYSE:…

Paul Ausick | Nov 22, 2011 at 4:06 PM EST

24/7 Wall St. Closing Bell (MSFT, GILD, NFLX, AMGN, WYNN, CREE, LDK, CPB, HRL, STP, BRCD, FRO, ALU, GRPN, FMCN, ROYL)

Stocks opened a bit lower this morning, but almost immediately turned around without being able to break through the opening…

Jon C. Ogg | Nov 22, 2011 at 8:29 AM EST

Top Analyst Upgrades & Downgrades (AMGN, AN, BXP, CREE, DOLE, GRMN, GILD, HIG, HAR, MSFT, NFLX, VRUS, TSN, WYNN, YUM)

These are some of Tuesday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls. Amgen Inc. (NASDAQ: AMGN)…

Paul Ausick | Nov 21, 2011 at 4:08 PM EST

24/7 Wall St. Closing Bell (AAPL, DV, MS, QCOM, TGT, WDC, HAST, TECD, TSN, HPQ, TSL, CSIQ, JKS, JASO, LDK, STP, LNKD, VRUS, GILD, FMCN, GEDU, REGN, Z)

Stock prices plunged this morning and spent most of the day trading way down. The DJIA hovered around -300 points…

Mike Sauter | Nov 21, 2011 at 8:57 AM EST

Top Active Trader Alert Stocks (GILD, RIMM, VRUS)

Crude oil is at $96.43, down 1.29% Gold is at $1,766, down 0.74%. Hong Kong’s Hang Seng closed down 1.44%…

Jon C. Ogg | Nov 21, 2011 at 7:51 AM EST

Gilead Paying Up (too much) for Pharmasset (GILD, VRUS)

Gilead Sciences Inc. (NASDAQ: GILD) is trading lower on news that it is spending some $11 billion to buy Pharmasset,…

Jon C. Ogg | Oct 19, 2011 at 11:34 AM EDT

Measuring Pre-Earnings Upside in Biotechs (DNDN, HGSI, GILD, AMLN, ARIA, INCY, IBB, XBI, BBH)

We have compiled a detailed list of expected upside in the biotech sector. The sector has consolidated and now there…

Jon C. Ogg | Sep 16, 2011 at 8:07 AM EDT

Top Analyst Upgrades & Downgrades (ADTN, AGN, AAPL, ADP, ABX, C, EXPE, GILD, LNKD, MA, NOK, OPEN, PWRD, RIMM, RGLD, TSM, AMTD, VECO)

Jon OggThese are some of this Friday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street…

Jon C. Ogg | Jun 29, 2011 at 8:04 AM EDT

Top Analyst Upgrades & Downgrades (AKS, ARMH, CMG, C, GILD, GS, KFT, MPEL, PVA, RIMM, SMP, X)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday…

Jon C. Ogg | Jun 12, 2011 at 9:40 AM EDT

Key Stocks To Watch This Coming Week, The Unusual Suspects (ADP, CSX, FVE, GILD, LYV, LULU, RMBS, REGN, RIMM, SIRI, P, SIX, VRX)

The upcoming week is not very active on the earnings front but we do have some key events to watch…

Douglas A. McIntyre | Apr 23, 2011 at 8:54 AM EDT

The Week’s Largest Market Losers

Iron Mountain’s proxy fight with Elliott Management continued, as the company added an Elliott board member and said it may…

Jon C. Ogg | Apr 11, 2011 at 2:01 PM EDT

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Biotech is becoming the ever-shrinking stock sector. It is almost weekly now that a new biotech acquisition is announced. Big Pharma in…

Jon C. Ogg | Mar 2, 2011 at 12:44 PM EST

Dividends For Biotech? (AMGN, GILD)

Investors love huge biotech opportunities for growth. Investors also love to get paid in the form of dividends. Unfortunately, the…

Jon C. Ogg | Dec 29, 2010 at 1:47 PM EST

Big Biotech: Best of 2010, Outlook in 2011 (ILMN, ITMN, INCY, THRX, VPHM, DNDN, AMGN, GILD, CELG, HGSI, ACOR)

2010 is ending and 2011 is about to begin. It has been a very interesting year for major biotech stocks,…

Jon C. Ogg | Dec 10, 2010 at 8:13 AM EST

Top Analyst Upgrades and Downgrades (ARG, IRE, BRCM, CPN, CELG, CIT, DRYS, GILD, INTC, LULU, MRVL, NVDA, PG, QCOM, RIMM, TXN)

These are some of this Friday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Airgas Inc.…

1 … 44 45 46 47 48 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Top Analyst Upgrades & Downgrades (AET, BIG, CIT, FMCN, GILD, JASO, LDK, MDR, MU, SNH, VE, INT)

24/7 Wall St. Closing Bell (MSFT, GILD, NFLX, AMGN, WYNN, CREE, LDK, CPB, HRL, STP, BRCD, FRO, ALU, GRPN, FMCN, ROYL)

Top Analyst Upgrades & Downgrades (AMGN, AN, BXP, CREE, DOLE, GRMN, GILD, HIG, HAR, MSFT, NFLX, VRUS, TSN, WYNN, YUM)

24/7 Wall St. Closing Bell (AAPL, DV, MS, QCOM, TGT, WDC, HAST, TECD, TSN, HPQ, TSL, CSIQ, JKS, JASO, LDK, STP, LNKD, VRUS, GILD, FMCN, GEDU, REGN, Z)

Top Active Trader Alert Stocks (GILD, RIMM, VRUS)

Gilead Paying Up (too much) for Pharmasset (GILD, VRUS)

Measuring Pre-Earnings Upside in Biotechs (DNDN, HGSI, GILD, AMLN, ARIA, INCY, IBB, XBI, BBH)

Top Analyst Upgrades & Downgrades (ADTN, AGN, AAPL, ADP, ABX, C, EXPE, GILD, LNKD, MA, NOK, OPEN, PWRD, RIMM, RGLD, TSM, AMTD, VECO)

Top Analyst Upgrades & Downgrades (AKS, ARMH, CMG, C, GILD, GS, KFT, MPEL, PVA, RIMM, SMP, X)

Key Stocks To Watch This Coming Week, The Unusual Suspects (ADP, CSX, FVE, GILD, LYV, LULU, RMBS, REGN, RIMM, SIRI, P, SIX, VRX)

The Week’s Largest Market Losers

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Dividends For Biotech? (AMGN, GILD)

Big Biotech: Best of 2010, Outlook in 2011 (ILMN, ITMN, INCY, THRX, VPHM, DNDN, AMGN, GILD, CELG, HGSI, ACOR)

Top Analyst Upgrades and Downgrades (ARG, IRE, BRCM, CPN, CELG, CIT, DRYS, GILD, INTC, LULU, MRVL, NVDA, PG, QCOM, RIMM, TXN)

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

JNK’s 0.40% Fee Quietly Costs You $6,000 Over 20 Years

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Gilead Sciences : GILD

All Gilead Sciences Articles

Top Analyst Upgrades & Downgrades (AET, BIG, CIT, FMCN, GILD, JASO, LDK, MDR, MU, SNH, VE, INT)

24/7 Wall St. Closing Bell (MSFT, GILD, NFLX, AMGN, WYNN, CREE, LDK, CPB, HRL, STP, BRCD, FRO, ALU, GRPN, FMCN, ROYL)

Top Analyst Upgrades & Downgrades (AMGN, AN, BXP, CREE, DOLE, GRMN, GILD, HIG, HAR, MSFT, NFLX, VRUS, TSN, WYNN, YUM)

24/7 Wall St. Closing Bell (AAPL, DV, MS, QCOM, TGT, WDC, HAST, TECD, TSN, HPQ, TSL, CSIQ, JKS, JASO, LDK, STP, LNKD, VRUS, GILD, FMCN, GEDU, REGN, Z)

Top Active Trader Alert Stocks (GILD, RIMM, VRUS)

Gilead Paying Up (too much) for Pharmasset (GILD, VRUS)

Measuring Pre-Earnings Upside in Biotechs (DNDN, HGSI, GILD, AMLN, ARIA, INCY, IBB, XBI, BBH)

Top Analyst Upgrades & Downgrades (ADTN, AGN, AAPL, ADP, ABX, C, EXPE, GILD, LNKD, MA, NOK, OPEN, PWRD, RIMM, RGLD, TSM, AMTD, VECO)

Top Analyst Upgrades & Downgrades (AKS, ARMH, CMG, C, GILD, GS, KFT, MPEL, PVA, RIMM, SMP, X)

Key Stocks To Watch This Coming Week, The Unusual Suspects (ADP, CSX, FVE, GILD, LYV, LULU, RMBS, REGN, RIMM, SIRI, P, SIX, VRX)

The Week’s Largest Market Losers

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Dividends For Biotech? (AMGN, GILD)

Big Biotech: Best of 2010, Outlook in 2011 (ILMN, ITMN, INCY, THRX, VPHM, DNDN, AMGN, GILD, CELG, HGSI, ACOR)

Top Analyst Upgrades and Downgrades (ARG, IRE, BRCM, CPN, CELG, CIT, DRYS, GILD, INTC, LULU, MRVL, NVDA, PG, QCOM, RIMM, TXN)

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

JNK’s 0.40% Fee Quietly Costs You $6,000 Over 20 Years

Featured Reads

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance